{rfName}

Indexed in

License and use

Altmetrics

Grant support

Financial support was provided by the Instituto de Salud Carlos III de Madrid (COV20/00110, ISCIII); Fondo Europeo de Desarrollo Regional (FEDER); Una manera de hacer Europa; Centro de Investigacion Biomedica En Red-Enfermedades Respiratorias (CIBERES); and Donation program estar preparados UNESPA, Madrid, Spain. DdGC has received financial support from the Instituto de Salud Carlos III (Miguel Servet 2020: CP20/00041), co-funded by European Social Fund (ESF)/ Investing in your future. Adrian Ceccato acknowledges receiving financial support from Instituto de Salud Carlos III (ISCIII; Sara Borrell 2021: CD21/00087).

Share

July 31, 2023
Publications
>
Article
No

Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients

Publicated to:Intensive Care Medicine. 49 (8): 934-945 - 2023-08-01 49(8), DOI: 10.1007/s00134-023-07161-1

Authors: Galli, Flavia; Bindo, Francesco; Motos, Anna; Fernandez-Barat, Laia; Barbeta, Enric; Gabarrus, Albert; Ceccato, Adrian; Bermejo-Martin, Jesus F; Ferrer, Ricard; Riera, Jordi; Penuelas, Oscar; Lorente, Jose Angel; de Gonzalo-Calvo, David; Menendez, Rosario; Gonzalez, Jessica; Misuraca, Sofia; Palomeque, Andrea; Amaya-Villar, Rosario; Anon, Jose Manuel; Balan Marino, Ana; Barbera, Carme; Barberan, Jose; Blandino Ortiz, Aaron; Bustamante-Munguira, Elena; Caballero, Jesus; Canton-Bulnes, Maria Luisa; Carbajales Perez, Cristina; Carbonell, Nieves; Catalan-Gonzalez, Mercedes; de Frutos, Raul; Franco, Nieves; Galban, Cristobal; Lopez Lago, Ana; Gumucio-Sanguino, Victor D; de la Torre, Maria del Carmen; Diaz, Emilio; Estella, Angel; Gallego Curto, Elena; Garcia-Garmendia, Jose Luis; Gomez, Jose Manuel; Huerta, Arturo; Jorge Garcia, Ruth Noemi; Loza-Vazquez, Ana; Marin-Corral, Judith; Martin Delgado, Maria Cruz; Martinez de la Gandara, Amalia; Martinez Varela, Ignacio; Lopez Messa, Juan; M Albaiceta, Guillermo; Nieto, Maria Teresa; Novo, Mariana Andrea; Penasco, Yhivian; Perez-Garcia, Felipe; Pozo-Laderas, Juan Carlos; Ricart, Pilar; Sagredo, Victor; Sanchez-Miralles, Angel; Sancho Chinesta, Susana; Roche-Campo, Ferran; Socias, Lorenzo; Sole-Violan, Jordi; Suarez-Sipmann, Fernando; Tamayo Lomas, Luis; Trenado, Jose; Ubeda, Alejandro; Valdivia, Luis Jorge; Vidal, Pablo; Boado, Maria Victoria; Rodriguez, Alejandro; Antonelli, Massimo; Blasi, Francesco; Barbe, Ferran; Torres, Antoni

Affiliations

August Pi i Sunyer Biomedical Research Institute-IDIBAPS, University of Barcelona, Barcelona, Spain. - Author
August Pi i Sunyer Biomedical Research Institute-IDIBAPS, University of Barcelona, Barcelona, Spain. lfernan1@recerca.clinic.cat. - Author
CIBER de Enfermedades Respiratorias (CIBERes), Instituto de Salud Carlos III, Madrid, Spain. - Author
CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain. lfernan1@recerca.clinic.cat. - Author
Clin Sagrada Familia, Pulm & Crit Care Div, Emergency Dept, Barcelona, Spain - Author
Complejo Asistencial Univ Palencia, Palencia 47, Spain - Author
Complejo Hosp Univ Santiago, Dept Crit Care Med, CHUS, Santiago, Spain - Author
Complexo Hosp Univ Ourense, Orense, Spain - Author
Critical Care Center, Institut d'Investigació i Innovació Parc Taulí I3PT, Parc Taulí Hospital Universitari, Sabadell, Spain. - Author
Critical Intensive Medicine Department, Hospital Universitari Arnau de Vilanova de Lleida, IRBLleida, Lleida, Spain. - Author
Department of Critical Care Medicine, CHUS, Complejo Hospitalario Universitario de Santiago, Santiago, Spain. - Author
Department of Intensive Care Medicine, Hospital Clínico Universitario Valladolid, Valladolid, Spain. - Author
Department of Intensive Care Medicine, Hospital Universitario 12 de Octubre, Madrid, Spain. - Author
Department of Intensive Care, Emergency Medicine and Anesthesia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. - Author
Department of Intensive Care, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain. - Author
Department of Medicine, Critical Care Department, Corporació Sanitària Parc Taulí, Universitat Autònoma de Barcelona (UAB), Sabadell, Barcelona, Spain. - Author
Department of Medicine, Intensive Care Unit University Hospital of Jerez, University of Cádiz, INIBiCA, Cádiz, Spain. - Author
Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy. - Author
Department of Pneumology, Hospital Clinic of Barcelona - Author
Dept. of Bioengineering, Universidad Carlos III, Madrid, Spain. - Author
Fdn IRCCS Ca Granda Osped Maggiore Policlin, Resp Unit & Cyst Fibrosis Adult Ctr, Milan, Italy - Author
Fdn Policlin Univ A Gemelli IRCCS, Dept Intens Care Emergency Med & Anesthesia, Rome, Italy - Author
Group for Biomedical Research in Sepsis (BioSepsis), Instituto de Investigación Biomédica de Salamanca (IBSAL), Paseo de San Vicente, Salamanca, Spain. - Author
Hosp Alvaro Cunqueiro, Intens Care Unit, Vigo, Spain - Author
Hosp Clin Barcelona, Dept Pulm Med, C-Villarroel 170, Barcelona 08036, Spain - Author
Hosp Clin Univ, Intens Care Unit, Valencia, Spain - Author
Hosp Clinico Univ Valladolid, Dept Intens Care Med, Valladolid, Spain - Author
Hosp Gen Segovia, Segovia, Spain - Author
Hosp Gen Univ Gregorio Maranon, Madrid, Spain - Author
Hosp Mar IMIM, Crit Care Dept, Barcelona, Spain - Author
Hosp Mataro Barcelona, Barcelona, Spain - Author
Hosp Nuestra Senora Gracia, Dept Intens Care, Zaragoza, Spain - Author
Hosp Punta Europa, Serv Med Intens, Algeciras, Spain - Author
Hosp San Juan Dios Aljarafe, Intens Care Unit, Seville, Spain - Author
Hosp Santa Maria, IRBLleida, Lleida, Spain - Author
Hosp Son Llatzer, Intens Care Unit, Palma De Mallorca, Spain - Author
Hosp Univ 12 Octubre, Dept Intens Care Med, Madrid, Spain - Author
Hosp Univ Aranu Vilanova & Santa Maria, IRBLleida, Resp Dept, Translat Res Resp Med, Lleida, Spain - Author
Hosp Univ Arnau Vilanova Lleida, Crit Intens Med Dept, IRBLleida, Lleida, Spain - Author
Hosp Univ Basurto, Serv Anestesiol Reanimac, Bilbao, Spain - Author
Hosp Univ Bellvitge, Bellvitge Biomed Res Inst IDIBELL, Dept Intens Care, Lhospitalet De Llobregat, Spain - Author
Hosp Univ Cruces, Baracaldo, Spain - Author
Hosp Univ Germans Trias, Serv Med Intens, Badalona, Spain - Author
Hosp Univ Infanta Leonor, Dept Intens Med, Madrid, Spain - Author
Hosp Univ La Paz, Serv Med Intensiva, IdiPAZ, Madrid, Spain - Author
Hosp Univ Leon, Leon, Spain - Author
Hosp Univ Lucus Augusti, Crit Care Dept, Lugo, Spain - Author
Hosp Univ Marques Valdecilla, Serv Med Intens, Santander, Spain - Author
Hosp Univ Mostoles, Madrid, Spain - Author
Hosp Univ Mutua Terrassa, Serv Med Intens, Barcelona, Spain - Author
Hosp Univ Politecn La Fe, Serv Med Intens, Valencia, Spain - Author
Hosp Univ Princesa, Intens Care Unit, Madrid, Spain - Author
Hosp Univ Ramon & Cajal, Serv Med Intens, Madrid, Spain - Author
Hosp Univ Rio Hortega Valladolid, Crit Care Dept, Valladolid, Spain - Author
Hosp Univ Rio Hortega Valladolid, Valladolid, Spain - Author
Hosp Univ Sagrat Cor, Intens Care Unit, Grp Quironsalud, Barcelona, Spain - Author
Hosp Univ Salamanca, Salamanca, Spain - Author
Hosp Univ San Pedro Alcantara, Unidad Cuidados Intensivos, Caceres, Spain - Author
Hosp Univ Sant Joan dAlacant, Intens Care Unit, Alicante, Spain - Author
Hosp Univ Son Espases, Serv Med Intens, Palma De Mallorca, Spain - Author
Hosp Univ Vall Hebron, Vall Hebron Inst Recerca, Dept Intens Care, Barcelona, Spain - Author
Hosp Univ Virgen Macarena, Intens Care Clin Unit, Seville, Spain - Author
Hosp Univ Virgen Rocio, Intens Care Clin Unit, Seville, Spain - Author
Hosp Univ Virgen Valme, Unidad Med Intens, Seville, Spain - Author
Hosp Verge Cinta, Inst Invest Sanitaria Pere Virgili IISPV, Tarragona, Spain - Author
Hospital de Mataró de Barcelona, Barcelona, Spain. - Author
Hospital Santa Maria, IRBLleida, Lleida, Spain. - Author
Hospital Universitario de Getafe, Universidad Europea, Madrid, Spain. - Author
Hospital Universitario de Móstoles, Madrid, Spain. - Author
Hospital Universitario HM Montepríncipe, Facultad HM Hospitales de Ciencias de la Salud, Universidad Camilo Jose Cela, Madrid, Spain. - Author
Hospital Universitario Río Hortega de Valladolid, Valladolid, Spain. - Author
Hospital Universitario San Agustín, Asturias, Spain. - Author
Inst Invest Biomed Salamanca IBSAL, Grp Biomed Res Sepsis BioSepsis, Salamanca, Spain - Author
Inst Salud Carlos III, CIBER Enfermedades Respiratorias CIBERES, Madrid, Spain - Author
Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Infecciosas CI, Madrid, Spain - Author
Intensive Care Clinical Unit, Hospital Universitario Virgen de Rocío, Seville, Spain. - Author
Intensive Care Clinical Unit, Hospital Universitario Virgen Macarena, Seville, Spain. - Author
Intensive Care Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institut de Recerca, Barcelona, Spain. - Author
Intensive Care Unit, and Emergency Medicine, Universidad de Alcalá, Madrid, Spain. - Author
Intensive Care Unit, Grupo Quironsalud, Hospital Universitari Sagrat Cor, Barcelona, Spain. - Author
Intensive Care Unit, Hospital Álvaro Cunqueiro, Vigo, Spain. - Author
Intensive Care Unit, Hospital Clínico Universitario, Valencia, Spain. - Author
Malalties metabòliques hereditàries i malalties musculars. Institut d'Investigacions Biomèdiques August Pi i Sunyer - Author
Parc Tauli Hosp Univ, Inst Invest Innovacio Parc Tauli I3PT, Crit Care Ctr, Sabadell, Spain - Author
Pulmonary Department, University and Polytechnic Hospital La Fe, Valencia, Spain. - Author
Respiratory Unit and Cystic Fibrosis Adult Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. - Author
Rovira & Virgili Univ, CIBERES, Crit Care Dept, Hosp Univ Joan 23, Tarragona, Spain - Author
Servicio de Anestesiología y Reanimación, Hospital Universitario Basurto, Bilbao, Spain. - Author
Servicio de Medicina Intensiva, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain. - Author
Servicio de Medicina Intensiva, Hospital Universitario Ramón y Cajal, Madrid, Spain. - Author
Spain Hosp Univ San Agustin, Asturias, Spain - Author
Translational Research in Respiratory Medicine, Respiratory Department, Hospital Universitari Aranu de Vilanova and Santa Maria, IRBLleida, Lleida, Spain. - Author
UGC Med Intens, Inst Maimonides IMIBIC, Hosp Univ Reina Sofia, Cordoba, Spain - Author
Unidad de Cuidados Intensivos, Hospital Universitario San Pedro de Alcántara, Cáceres, Spain. - Author
Univ & Polytechn Hosp La Fe, Dept Pulm, Valencia, Spain - Author
Univ Alcala, Fac Med, Dept Biomed Biotecnol, Serv Microbiol Clin,Hosp Univ Principe Asturias, Alcala De Henares, Spain - Author
Univ Alcala, Intens Care Unit & Emergency Med, Madrid, Spain - Author
Univ Autonoma Barcelona UAB, Corporacio Sanitaria Parc Tauli, Crit Care Dept, Dept Med, Barcelona, Spain - Author
Univ Barcelona, Hosp Clin Barcelona August Pi Sunyer Biomed Res I, Dept Pneumol, Barcelona, Spain - Author
Univ Cadiz, Dept Med, Intens Care Unit, INIBiCA,Univ Hosp Jerez, Cadiz, Spain - Author
Univ Camilo Jose Cela, Hosp Univ HM Monteprincipe, Fac HM Hosp Ciencias Salud, Madrid, Spain - Author
Univ Carlos III, Dept Bioengn, Madrid, Spain - Author
Univ Cattolica Sacro Cuore, Rome, Italy - Author
Univ Europea, Hosp Univ Getafe, Madrid, Spain - Author
Univ Fernando Pessoa Canarias, Hosp Univ GC Dr Negrin, Crit Care Dept, Gran Canaria, Spain - Author
Univ Francisco Vitoria, Hosp Univ Torrejon, Madrid, Spain - Author
Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy - Author
Univ Oviedo, Inst Univ Oncol Principado Asturias, Inst Invest Sanitaria Principado Asturias, Hosp Cent Asturias,Dept Biol Func, Oviedo, Spain - Author
Università Cattolica del Sacro Cuore, Rome, Italy. - Author
See more

Abstract

Although the prevalence of community-acquired respiratory bacterial coinfection upon hospital admission in patients with coronavirus disease 2019 (COVID-19) has been reported to be < 5%, almost three-quarters of patients received antibiotics. We aim to investigate whether procalcitonin (PCT) or C-reactive protein (CRP) upon admission could be helpful biomarkers to identify bacterial coinfection among patients with COVID-19 pneumonia.We carried out a multicentre, observational cohort study including consecutive COVID-19 patients admitted to 55 Spanish intensive care units (ICUs). The primary outcome was to explore whether PCT or CRP serum levels upon hospital admission could predict bacterial coinfection among patients with COVID-19 pneumonia. The secondary outcome was the evaluation of their association with mortality. We also conducted subgroups analyses in higher risk profile populations.Between 5 February 2020 and 21 December 2021, 4076 patients were included, 133 (3%) of whom presented bacterial coinfection. PCT and CRP had low area under curve (AUC) scores at the receiver operating characteristic (ROC) curve analysis [0.57 (95% confidence interval (CI) 0.51-0.61) and 0.6 (95% CI, 0.55-0.64), respectively], but high negative predictive values (NPV) [97.5% (95% CI 96.5-98.5) and 98.2% (95% CI 97.5-98.9) for PCT and CRP, respectively]. CRP alone was associated with bacterial coinfection (OR 2, 95% CI 1.25-3.19; p = 0.004). The overall 15, 30 and 90 days mortality had a higher trend in the bacterial coinfection group, but without significant difference. PCT ≥ 0.12 ng/mL was associated with higher 90 days mortality.Our study suggests that measurements of PCT and CRP, alone and at a single time point, are not useful for ruling in or out bacterial coinfection in viral pneumonia by COVID-19.© 2023. The Author(s).

Keywords

adultsbacterial coinfectionc-reactive proteincovid-19critically illdecisiondiagnosisetiologyinfectionintensive caremortalitysepsisserum procalcitoninstatistics notesAdultAgedAntibiotic agentArea under the curveArticleBacterial coinfectionBacterial infectionBiological markerBiomarkersC reactive proteinC-reactive proteinCalcitoninCohort analysisCoinfectionCommunity-acquired pneumoniaComplicationControlled studyCoronavirus disease 2019CorticosteroidCovid-19Critical illnessCritically illCritically ill patientDiagnostic test accuracy studyFemaleHospital admissionHumanHumansIntensive careMajor clinical studyMaleMetabolismMortalityMortality rateObservational studyPredictive valueProcalcitoninProtein blood levelReceiver operating characteristicRetrospective studiesRetrospective studyRoc curveSensitivity and specificity

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Intensive Care Medicine due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2023, it was in position 2/55, thus managing to position itself as a Q1 (Primer Cuartil), in the category Critical Care Medicine. Notably, the journal is positioned above the 90th percentile.

From a relative perspective, and based on the normalized impact indicator calculated from World Citations provided by WoS (ESI, Clarivate), it yields a value for the citation normalization relative to the expected citation rate of: 3.4. This indicates that, compared to works in the same discipline and in the same year of publication, it ranks as a work cited above average. (source consulted: ESI Nov 14, 2024)

This information is reinforced by other indicators of the same type, which, although dynamic over time and dependent on the set of average global citations at the time of their calculation, consistently position the work at some point among the top 50% most cited in its field:

  • Weighted Average of Normalized Impact by the Scopus agency: 3.11 (source consulted: FECYT Feb 2024)
  • Field Citation Ratio (FCR) from Dimensions: 18.67 (source consulted: Dimensions Jul 2025)

Specifically, and according to different indexing agencies, this work has accumulated citations as of 2025-07-04, the following number of citations:

  • WoS: 17
  • Scopus: 14
  • Europe PMC: 9

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-07-04:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 35.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 45 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 54.15.
  • The number of mentions on the social network Facebook: 1 (Altmetric).
  • The number of mentions on the social network X (formerly Twitter): 85 (Altmetric).

Leadership analysis of institutional authors

This work has been carried out with international collaboration, specifically with researchers from: Italy.

There is a significant leadership presence as some of the institution’s authors appear as the first or last signer, detailed as follows: Last Author (Torres Martí, Antoni).

the authors responsible for correspondence tasks have been Fernández Barat, Laia and Torres Martí, Antoni.